Patents Assigned to GI THERAPIES PTY LTD
  • Patent number: 10279174
    Abstract: A device for transcutaneous electrical stimulation is provided. The device comprises circuitry configured to generate transcutaneous stimulation signals. The device also comprises a first signal output component for electrically connecting to a first electrode connector to deliver generated transcutaneous stimulation signals. The first signal output component comprises a first four-pole electrical connector part. The device further comprises a second signal output component for electrically connecting to a second electrode connector to deliver generated transcutaneous stimulation signals. The second signal output component comprises a second four-pole electrical connector part. The device further comprises a controller to selectively control output of the stimulation signals to selected pairs of poles across the first and second four-pole electrical connector parts.
    Type: Grant
    Filed: November 20, 2017
    Date of Patent: May 7, 2019
    Assignee: GI Therapies Pty Ltd
    Inventors: Bridget Rae Southwell, Rod Wiebenga, David Fisher
  • Patent number: 10279175
    Abstract: An electrode connector assembly for the use in transcutaneous electrical stimulation includes a flexible web extending in a plane and first, second, third and fourth electrode connectors carried by the web and spaced from each other about the web in the plane. The electrode connector assembly further includes an electrical connector and first, second, third and fourth conductors electrically coupling the respective first, second, third and fourth electrode connectors to the electrical connector.
    Type: Grant
    Filed: March 29, 2018
    Date of Patent: May 7, 2019
    Assignee: GI Therapies Pty Ltd
    Inventors: Bridget Rae Southwell, David Fisher, Rod Wiebenga, Lisa Tjernberg
  • Patent number: 9962544
    Abstract: An electrode connector assembly for use in transcutaneous electrical stimulation includes a flexible web extending in a plane and first, second, third and fourth electrode connectors carried by the web and spaced from each other about the web in the plane. The electrode connector assembly further includes an electrical connector and first, second, third and fourth conductors electrically coupling the respective first, second, third and fourth electrode connectors to the electrical connector.
    Type: Grant
    Filed: October 10, 2014
    Date of Patent: May 8, 2018
    Assignee: GI Therapies Pty Ltd
    Inventors: Bridget Rae Southwell, David Fisher, Rod Wiebenga, Lisa Tjernberg
  • Patent number: 9827418
    Abstract: A device for transcutaneous electrical stimulation is provided. The device comprises circuitry configured to generate transcutaneous stimulation signals. The device also comprises a first signal output component for electrically connecting to a first electrode connector to deliver generated transcutaneous stimulation signals. The first signal output component comprises a first four-pole electrical connector part. The device further comprises a second signal output component for electrically connecting to a second electrode connector to deliver generated transcutaneous stimulation signals. The second signal output component comprises a second four-pole electrical connector part. The device further comprises a controller to selectively control output of the stimulation signals to selected pairs of poles across the first and second four-pole electrical connector parts.
    Type: Grant
    Filed: October 10, 2014
    Date of Patent: November 28, 2017
    Assignee: GI Therapies Pty Ltd
    Inventors: Bridget Rae Southwell, Rod Wiebenga, David Fisher
  • Publication number: 20160235981
    Abstract: A device for transcutaneous electrical stimulation is provided. The device comprises circuitry configured to generate transcutaneous stimulation signals. The device also comprises a first signal output component for electrically connecting to a first electrode connector to deliver generated transcutaneous stimulation signals. The first signal output component comprises a first four-pole electrical connector part. The device further comprises a second signal output component for electrically connecting to a second electrode connector to deliver generated transcutaneous stimulation signals. The second signal output component comprises a second four-pole electrical connector part. The device further comprises a controller to selectively control output of the stimulation signals to selected pairs of poles across the first and second four-pole electrical connector parts.
    Type: Application
    Filed: October 10, 2014
    Publication date: August 18, 2016
    Applicant: GI THERAPIES PTY LTD
    Inventors: Bridget Rae Southwell, Rod Wiebenga, David Fisher